Macrophages and progressive tubulointerstitial disease
- PMID: 16014021
- DOI: 10.1111/j.1523-1755.2005.00422.x
Macrophages and progressive tubulointerstitial disease
Abstract
Macrophages and progressive tubulointerstitial disease. In chronic renal disease, tubulointerstitial inflammation and injury is associated with infiltrating macrophages. As a consequence of primary injury, proteinuria, chronic hypoxia, and glomerular-derived cytokines may all differentially modulate the expression of factors that promote macrophage recruitment. In addition to adhesion molecules and chemokines, products of complement system and renin-angiotensin system activation may direct this process. Once present at interstitial sites, macrophages interact with resident cells and extracellular matrix to generate a proinflammatory microenvironment that amplifies tissues injury and promotes scarring. There is now increasing evidence for the efficacy of interventions directed against factors that recruit, activate, or are produced by macrophages. A detailed understanding of the biology of this area may lead to the further development of therapies that will improve the outcome of renal disease.
Similar articles
-
More on renal disease progression: is interstitial inflammation truly protective?J Am Soc Nephrol. 2007 Jun;18(6):1630-2. doi: 10.1681/ASN.2007040474. Epub 2007 May 18. J Am Soc Nephrol. 2007. PMID: 17513321 No abstract available.
-
Macrophages and hypoxia in human chronic kidney disease.Kidney Int. 2008 Aug;74(4):405-6. doi: 10.1038/ki.2008.225. Kidney Int. 2008. PMID: 18670402
-
Experimental insights into the tubulointerstitial disease accompanying primary glomerular lesions.J Am Soc Nephrol. 1994 Dec;5(6):1273-87. doi: 10.1681/ASN.V561273. J Am Soc Nephrol. 1994. PMID: 7893992 Review.
-
The role of tubulointerstitial inflammation in the progression of chronic renal failure.Nephron Clin Pract. 2010;116(2):c81-8. doi: 10.1159/000314656. Epub 2010 May 22. Nephron Clin Pract. 2010. PMID: 20502043 Review.
-
Oxidant stress and regulation of chemokines in the development of renal interstitial fibrosis.Contrib Nephrol. 2003;139:102-19. doi: 10.1159/000071739. Contrib Nephrol. 2003. PMID: 12854321 Review. No abstract available.
Cited by
-
AIM2 facilitates the apoptotic DNA-induced systemic lupus erythematosus via arbitrating macrophage functional maturation.J Clin Immunol. 2013 Jul;33(5):925-37. doi: 10.1007/s10875-013-9881-6. Epub 2013 Mar 12. J Clin Immunol. 2013. PMID: 23479181
-
Epithelial-mesenchymal transition (EMT) of renal tubular cells in canine glomerulonephritis.Virchows Arch. 2007 Nov;451(5):937-42. doi: 10.1007/s00428-007-0482-8. Epub 2007 Aug 15. Virchows Arch. 2007. PMID: 17701211
-
Esaxerenone inhibits the macrophage-to-myofibroblast transition through mineralocorticoid receptor/TGF-β1 pathway in mice induced with aldosterone.Front Immunol. 2022 Sep 6;13:948658. doi: 10.3389/fimmu.2022.948658. eCollection 2022. Front Immunol. 2022. PMID: 36148244 Free PMC article.
-
Pathogenic and protective role of macrophages in kidney disease.Am J Physiol Renal Physiol. 2013 Jul 1;305(1):F3-11. doi: 10.1152/ajprenal.00122.2013. Epub 2013 May 1. Am J Physiol Renal Physiol. 2013. PMID: 23637206 Free PMC article. Review.
-
Hydrogen Sulfide as a Potential Therapeutic Target in Fibrosis.Oxid Med Cell Longev. 2015;2015:593407. doi: 10.1155/2015/593407. Epub 2015 May 11. Oxid Med Cell Longev. 2015. PMID: 26078809 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials